Does the media favor CLPT or GUTS?

In the previous week, Fractyl Health had 1 more articles in the media than ClearPoint Neuro. MarketBeat recorded 3 mentions for Fractyl Health and 2 mentions for ClearPoint Neuro. Fractyl Health's average media sentiment score of 1.17 beat ClearPoint Neuro's score of 0.85 indicating that Fractyl Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ClearPoint Neuro 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fractyl Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor DCTH or GUTS?

In the previous week, Fractyl Health had 1 more articles in the media than Delcath Systems. MarketBeat recorded 3 mentions for Fractyl Health and 2 mentions for Delcath Systems. Fractyl Health's average media sentiment score of 1.17 beat Delcath Systems' score of 0.94 indicating that Fractyl Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fractyl Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to GUTS or SI?

In the previous week, Fractyl Health had 1 more articles in the media than Shoulder Innovations. MarketBeat recorded 3 mentions for Fractyl Health and 2 mentions for Shoulder Innovations. Fractyl Health's average media sentiment score of 1.17 beat Shoulder Innovations' score of 1.00 indicating that Fractyl Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fractyl Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, CV or GUTS?

CapsoVision has higher revenue and earnings than Fractyl Health. CapsoVision is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CapsoVision $13.55M 23.93 -$25.32M -$2.34 N/A Fractyl Health $90K 1,362.63 -$140.95M -$1.29 N/A

Which has preferable valuation & earnings, GUTS or ELMD?

Electromed has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fractyl Health $90K 1,362.63 -$140.95M -$1.29 N/A Electromed $71.75M 4.43 $5.15M $1.17 32.83

Is GUTS or ELMD more profitable?

Electromed has a net margin of 11.34% compared to Fractyl Health's net margin of 0.00%. Electromed's return on equity of 15.71% beat Fractyl Health's return on equity. Company Net Margins Return on Equity Return on Assets Fractyl Health N/A -4,053.15% -96.41% Electromed 11.34% 15.71% 13.37%

Fractyl Health (GUTS) Competitors

$0.77 +0.02 (+2.15%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$0.77 0.00 (-0.13%)

As of 07/24/2026 07:34 PM Eastern

Compare

GUTS vs. CLPT, DCTH, SI, CV, and ELMD

Should you buy Fractyl Health stock or one of its competitors? MarketBeat compares Fractyl Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fractyl Health include ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Shoulder Innovations (SI), CapsoVision (CV), and Electromed (ELMD). These companies are all part of the "medical equipment" industry.

How does Fractyl Health compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends.

In the previous week, Fractyl Health had 1 more articles in the media than ClearPoint Neuro. MarketBeat recorded 3 mentions for Fractyl Health and 2 mentions for ClearPoint Neuro. Fractyl Health's average media sentiment score of 1.17 beat ClearPoint Neuro's score of 0.85 indicating that Fractyl Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ClearPoint Neuro	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fractyl Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

30.1% of ClearPoint Neuro shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by insiders. Comparatively, 8.5% of Fractyl Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

ClearPoint Neuro has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.29, indicating that its share price is 129% more volatile than the broader market.

ClearPoint Neuro presently has a consensus target price of $23.00, indicating a potential upside of 62.89%. Fractyl Health has a consensus target price of $5.12, indicating a potential upside of 562.35%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts clearly believe Fractyl Health is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

ClearPoint Neuro has higher revenue and earnings than Fractyl Health. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$40.61M	10.43	-$25.54M	-$1.01	N/A
Fractyl Health	$90K	1,362.63	-$140.95M	-$1.29	N/A

Fractyl Health has a net margin of 0.00% compared to ClearPoint Neuro's net margin of -71.57%. ClearPoint Neuro's return on equity of -140.96% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-71.57%	-140.96%	-36.98%
Fractyl Health	N/A	-4,053.15%	-96.41%

Summary

Fractyl Health beats ClearPoint Neuro on 10 of the 16 factors compared between the two stocks.

How does Fractyl Health compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

Delcath Systems has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.29, suggesting that its share price is 129% more volatile than the broader market.

Delcath Systems has a net margin of 0.62% compared to Fractyl Health's net margin of 0.00%. Delcath Systems' return on equity of 0.51% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Fractyl Health	N/A	-4,053.15%	-96.41%

In the previous week, Fractyl Health had 1 more articles in the media than Delcath Systems. MarketBeat recorded 3 mentions for Fractyl Health and 2 mentions for Delcath Systems. Fractyl Health's average media sentiment score of 1.17 beat Delcath Systems' score of 0.94 indicating that Fractyl Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fractyl Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Delcath Systems currently has a consensus price target of $22.17, indicating a potential upside of 81.40%. Fractyl Health has a consensus price target of $5.12, indicating a potential upside of 562.35%. Given Fractyl Health's higher possible upside, analysts clearly believe Fractyl Health is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Delcath Systems has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$90.44M	4.66	$2.70M	$0.01	1,222.00
Fractyl Health	$90K	1,362.63	-$140.95M	-$1.29	N/A

61.1% of Delcath Systems shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by insiders. Comparatively, 8.5% of Fractyl Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Delcath Systems beats Fractyl Health on 11 of the 16 factors compared between the two stocks.

How does Fractyl Health compare to Shoulder Innovations?

Fractyl Health (NASDAQ:GUTS) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

Shoulder Innovations has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	$90K	1,362.63	-$140.95M	-$1.29	N/A
Shoulder Innovations	$47.32M	8.95	-$40.36M	-$166.96	N/A

Fractyl Health presently has a consensus price target of $5.12, suggesting a potential upside of 562.35%. Shoulder Innovations has a consensus price target of $21.00, suggesting a potential upside of 2.84%. Given Fractyl Health's higher probable upside, equities research analysts clearly believe Fractyl Health is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Fractyl Health has a net margin of 0.00% compared to Shoulder Innovations' net margin of -81.78%. Shoulder Innovations' return on equity of -35.11% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

In the previous week, Fractyl Health had 1 more articles in the media than Shoulder Innovations. MarketBeat recorded 3 mentions for Fractyl Health and 2 mentions for Shoulder Innovations. Fractyl Health's average media sentiment score of 1.17 beat Shoulder Innovations' score of 1.00 indicating that Fractyl Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fractyl Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Shoulder Innovations beats Fractyl Health on 7 of the 13 factors compared between the two stocks.

How does Fractyl Health compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership, media sentiment and dividends.

CapsoVision currently has a consensus target price of $8.50, indicating a potential upside of 30.97%. Fractyl Health has a consensus target price of $5.12, indicating a potential upside of 562.35%. Given Fractyl Health's higher probable upside, analysts plainly believe Fractyl Health is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

CapsoVision has higher revenue and earnings than Fractyl Health. CapsoVision is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	23.93	-$25.32M	-$2.34	N/A
Fractyl Health	$90K	1,362.63	-$140.95M	-$1.29	N/A

In the previous week, Fractyl Health had 2 more articles in the media than CapsoVision. MarketBeat recorded 3 mentions for Fractyl Health and 1 mentions for CapsoVision. CapsoVision's average media sentiment score of 1.89 beat Fractyl Health's score of 1.17 indicating that CapsoVision is being referred to more favorably in the media.

Company	Overall Sentiment
CapsoVision	Very Positive
Fractyl Health	Positive

Fractyl Health has a net margin of 0.00% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Fractyl Health	N/A	-4,053.15%	-96.41%

Summary

Fractyl Health beats CapsoVision on 8 of the 13 factors compared between the two stocks.

How does Fractyl Health compare to Electromed?

Fractyl Health (NASDAQ:GUTS) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

40.8% of Electromed shares are owned by institutional investors. 8.5% of Fractyl Health shares are owned by company insiders. Comparatively, 10.5% of Electromed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Fractyl Health currently has a consensus price target of $5.12, indicating a potential upside of 562.35%. Electromed has a consensus price target of $37.50, indicating a potential downside of 2.37%. Given Fractyl Health's higher possible upside, equities analysts clearly believe Fractyl Health is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Fractyl Health has a beta of 2.29, indicating that its share price is 129% more volatile than the broader market. Comparatively, Electromed has a beta of 0.5, indicating that its share price is 50% less volatile than the broader market.

Electromed has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	$90K	1,362.63	-$140.95M	-$1.29	N/A
Electromed	$71.75M	4.43	$5.15M	$1.17	32.83

In the previous week, Fractyl Health had 3 more articles in the media than Electromed. MarketBeat recorded 3 mentions for Fractyl Health and 0 mentions for Electromed. Fractyl Health's average media sentiment score of 1.17 beat Electromed's score of 0.00 indicating that Fractyl Health is being referred to more favorably in the media.

Company	Overall Sentiment
Fractyl Health	Positive
Electromed	Neutral

Electromed has a net margin of 11.34% compared to Fractyl Health's net margin of 0.00%. Electromed's return on equity of 15.71% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
Electromed	11.34%	15.71%	13.37%

Summary

Electromed beats Fractyl Health on 10 of the 16 factors compared between the two stocks.

Get Fractyl Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GUTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GUTS vs. The Competition

Export

Metric	Fractyl Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$120.05M	$3.06B	$6.86B	$12.25B
Dividend Yield	N/A	2.07%	2.67%	9.79%
P/E Ratio	-0.60	20.29	27.14	23.64
Price / Sales	1,362.63	485.21	517.01	89.03
Price / Cash	N/A	27.62	50.54	59.64
Price / Book	11.04	4.13	10.28	6.07
Net Income	-$140.95M	$65.94M	$3.60B	$331.99M
7 Day Performance	-4.57%	-4.16%	-1.27%	-0.63%
1 Month Performance	-3.24%	-3.76%	-0.37%	-2.00%
1 Year Performance	-59.74%	9.94%	18.30%	13.62%

Fractyl Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GUTS Fractyl Health	3.8396 of 5 stars	$0.77 +2.2%	$5.12 +562.4%	-59.5%	$120.05M	$90K	N/A	102
CLPT ClearPoint Neuro	2.7618 of 5 stars	$15.34 +1.9%	$23.00 +49.9%	+25.2%	$460.11M	$36.97M	N/A	110	News Coverage
DCTH Delcath Systems	2.702 of 5 stars	$12.68 -1.1%	$22.17 +74.9%	+7.2%	$437.54M	$85.23M	1,267.50	60	News Coverage
SI Shoulder Innovations	1.6475 of 5 stars	$20.92 -0.4%	$21.00 +0.4%	N/A	$433.78M	$47.32M	N/A	61
CV CapsoVision	2.7265 of 5 stars	$6.92 +2.5%	$8.50 +22.8%	+52.0%	$345.72M	$13.55M	N/A	90

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GUTS) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fractyl Health (GUTS) Competitors

GUTS vs. CLPT, DCTH, SI, CV, and ELMD

How does Fractyl Health compare to ClearPoint Neuro?

Summary

How does Fractyl Health compare to Delcath Systems?

Summary

How does Fractyl Health compare to Shoulder Innovations?

Summary

How does Fractyl Health compare to CapsoVision?

Summary

How does Fractyl Health compare to Electromed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GUTS vs. The Competition

Fractyl Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fractyl Health (GUTS) Competitors

GUTS vs. CLPT, DCTH, SI, CV, and ELMD

How does Fractyl Health compare to ClearPoint Neuro?

Does the media favor CLPT or GUTS?

Do insiders & institutionals believe in CLPT or GUTS?

Which has more volatility & risk, CLPT or GUTS?

Do analysts recommend CLPT or GUTS?

Which has preferable earnings and valuation, CLPT or GUTS?

Is CLPT or GUTS more profitable?

Summary

How does Fractyl Health compare to Delcath Systems?

Which has more volatility and risk, DCTH or GUTS?

Is DCTH or GUTS more profitable?

Does the media favor DCTH or GUTS?

Do analysts rate DCTH or GUTS?

Which has better earnings & valuation, DCTH or GUTS?

Do insiders & institutionals have more ownership in DCTH or GUTS?

Summary

How does Fractyl Health compare to Shoulder Innovations?

Which has higher valuation and earnings, GUTS or SI?

Do analysts rate GUTS or SI?

Is GUTS or SI more profitable?

Does the media refer more to GUTS or SI?

Summary

How does Fractyl Health compare to CapsoVision?

Do analysts recommend CV or GUTS?

Which has better valuation & earnings, CV or GUTS?

Does the media prefer CV or GUTS?

Is CV or GUTS more profitable?

Summary

How does Fractyl Health compare to Electromed?

Do insiders and institutionals have more ownership in GUTS or ELMD?

Do analysts rate GUTS or ELMD?

Which has more volatility & risk, GUTS or ELMD?

Which has preferable valuation & earnings, GUTS or ELMD?

Does the media refer more to GUTS or ELMD?

Is GUTS or ELMD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GUTS vs. The Competition

Fractyl Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools